Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives

Immunotherapy of malignant gliomas with autologous dendritic cells (DC) in addition to surgery and radiochemotherapy has been a focus of intense research during the past decade. Since both children and adults are affected by this highly aggressive brain tumor, 10-15% of the several hundred vaccinate...

Full description

Bibliographic Details

Published in:	Frontiers in Pediatrics
Main Authors:	Matthias eEyrich, Matthias eWölfl, Johannes eRachor, Susanne C Schreiber, Paul G Schlegel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-06-01
Subjects:	Immunotherapy Pediatrics Clinical Trial malignant glioma DC vaccination
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fped.2013.00012/full